CD47
39 programs · 39 companies
Programs
39
Companies
39
Active Trials
29
Targeting CD47
| Drug | Company | Phase | MOA | Indications |
|---|---|---|---|---|
| LLY-8903 | Eli Lilly | Preclinical | Huntington'sAsthma | |
| GSK-4334 | GSK | Preclinical | LN | |
| Motainavolisib | Amgen | NDA/BLA | PompeAngelman | |
| BMR-1165 | BioMarin | Phase 2 | GAIPF | |
| INC-2432 | Incyte | Phase 2 | FTDADHD | |
| Cevifotisoran | Neurocrine | Approved | NarcolepsyCKD | |
| Pemiinavolisib | Sarepta | NDA/BLA | CTCLPBC | |
| Terazumab | Akero | NDA/BLA | CholangiocarcinomaHS | |
| Lisonesiran | Passage Bio | NDA/BLA | GA | |
| Mavuvorutinib | Astellas | Phase 1/2 | UCRA | |
| SWO-IIT-447 | SWOG | Approved | OCD | |
| VIG-6767 | Vigil Neuro | Phase 2/3 | SchizophreniaRett | |
| Olpaosocimab | Flagship Labs | NDA/BLA | AMLPNH | |
| Lirabrutinib | Correvio (Advanz) | Phase 2/3 | Breast Ca | |
| Tiramavacamten | Lucid Diagnostics | Phase 2/3 | DravetMDS | |
| AER-8916 | Aerpio Pharmaceutics | Approved | GA | |
| CAN-4040 | Can-Fite BioPharma | Phase 1/2 | NMOSDLGS | |
| CGE-1983 | Compugen | Phase 2/3 | NMOSD | |
| Rilufutibatinib | Kumquat Bio | NDA/BLA | CRC | |
| FLA-5216 | Flatiron Health (Roche) | Approved | CMLMeso | |
| Bemarapivir | Celltrion | Approved | CKD | |
| 195-9888 | HK Inno.N | Phase 1/2 | PsA | |
| 095-6690 | Genexine | NDA/BLA | SCLC | |
| GLO-6047 | Gloria Bio | Preclinical | PsoriasisFSGS | |
| Zanurapivir | Brainsway | Phase 2 | BCCFSGS | |
| TWS-2496 | Twist Bioscience | Phase 2/3 | MesoAngelman | |
| FER-2526 | Ferring Pharma | NDA/BLA | OCDCML | |
| Semalemzoparlimab | Tolmar | Phase 1/2 | Wet AMD | |
| ITA-4515 | Italfarmaco | Phase 3 | Huntington's | |
| Voxanesiran | Lupin Limited | Phase 1 | AngelmanTTR Amyloidosis | |
| Mavuderotide | Cristalia | Approved | FLWilms | |
| Liravorutinib | SPIMACO | Approved | GAIPF | |
| INS-IIT-513 | Institut Curie | Phase 3 | FSGS | |
| IRC-IIT-214 | IRCCS San Raffaele | Phase 2 | Rett | |
| PRI-IIT-807 | Princess Margaret | Phase 2/3 | IPF | |
| NAT-IIT-627 | National Univ Hospital | Phase 1 | Heart Failure | |
| ANG-192 | Angelini Pharma | Phase 3 | MMSCD | |
| VET-4016 | Vetoquinol | Phase 1/2 | Pancreatic Ca | |
| Kemalucimab | Zhejiang Jiuzi | Phase 2/3 | MCCCrohn's |